Bioavailability Enhancement

Bend Research Improves Speed-to-Clinic Capability for Oral and Inhalation Formulation Development

Date of Release: 
October 29, 2013

Bend, Ore. – Bend Research Inc., part of Capsugel’s Dosage Form Solutions business unit, announced the addition of Capsugel’s Xcelodose® precision powder-filling technology to its drug development process.  This patented micro-dosing technology will further enhance Bend Research’s recently announced Rapid Advancement of Preclinical Compounds initiative. The technology will also facilitate fast and efficient scale up and transfer of powder-fill formulations within Capsugel’s global network of commercial production sites.

 

Continue Reading

Pages

Subscribe to RSS - Bioavailability Enhancement